Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAC-TIDE: Ticagrelor Monotherapy in Stent-Assisted Coiling
NCT06015477Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ticagrelor in brain aneurysm (IA) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Hemorrhage at 1 year and Composite endpoint of all-cause mortality, cerebrovascular accident or urgent target vessel revascularization at 1 year. Started Jan 2024; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NCT06015477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015477.